HL7 FHIR Implementation Guide: Glucose Monitoring
1.0.0 - STU1 Belgium flag

HL7 FHIR Implementation Guide: Glucose Monitoring, published by eHealth Platform. This guide is not an authorized publication; it is the continuous build for version 1.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-be/glucose-monitoring/ and changes regularly. See the Directory of published versions

ValueSet: BeVSDiabetesObservationCode

Official URL: https://www.ehealth.fgov.be/standards/fhir/glucose-monitoring/ValueSet/be-vs-diabetes-observation-code Version: 1.0.0
Draft as of 2025-09-10 Computable Name: BeVSDiabetesObservationCode

Values to be used in the code of Diabetes observations

References

Logical Definition (CLD)

  • Include these codes as defined in http://snomed.info/sct version http://snomed.info/sct/11000172109
    CodeDisplay
    141191000172105Percentage of time above level 1 hyperglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device
    141201000172108Percentage of time above level 2 hyperglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device
    141231000172103Percentage of time in target glucose range to total glucose monitoring time using minimally-invasive continuous glucose monitoring device
    141211000172106Percentage of time below level 1 hypoglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device
    141221000172101Percentage of time below level 2 hypoglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device
    141151000172102Mean number of point-of-care capillary blood glucose measurements per day
    141171000172109Number of clinically significant hypoglycaemic episodes recorded by continuous glucose monitoring device
    141141000172104Frequency of hyperglycaemic episodes
    365845005Hemoglobin A1C - diabetic control finding
    141161000172100Mean substance concentration of glucose in capillary blood using minimally-invasive continuous glucose monitoring device
    141121000172108Coefficient of variation
    141131000172106Days sensor worn
    141181000172107Percentage of data captured
    141241000172105Glucose management index

 

Expansion

Expansion from apps.health.belgium.be based on SNOMED CT Belgian Edition edition 15-Jul 2025

This value set contains 14 concepts

CodeSystemDisplay
  141121000172108http://snomed.info/sctCoefficient of variation
  141131000172106http://snomed.info/sctDays sensor worn
  141141000172104http://snomed.info/sctFrequency of hyperglycaemic episodes
  141241000172105http://snomed.info/sctGlucose management index
  365845005http://snomed.info/sctHemoglobin A1C - diabetic control finding
  141151000172102http://snomed.info/sctMean number of point-of-care capillary blood glucose measurements per day
  141161000172100http://snomed.info/sctMean substance concentration of glucose in capillary blood using minimally-invasive continuous glucose monitoring device
  141171000172109http://snomed.info/sctNumber of clinically significant hypoglycaemic episodes recorded by continuous glucose monitoring device
  141181000172107http://snomed.info/sctPercentage of data captured
  141191000172105http://snomed.info/sctPercentage of time above level 1 hyperglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device
  141201000172108http://snomed.info/sctPercentage of time above level 2 hyperglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device
  141211000172106http://snomed.info/sctPercentage of time below level 1 hypoglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device
  141221000172101http://snomed.info/sctPercentage of time below level 2 hypoglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device
  141231000172103http://snomed.info/sctPercentage of time in target glucose range to total glucose monitoring time using minimally-invasive continuous glucose monitoring device

Additional Language Displays

CodeEnglish (English, en)English (English, en)English (English, en)French (fr)French (fr)Nederlands (Dutch, nl)Nederlands (Dutch, nl)
141121000172108Coefficient of variation (observable entity)Coefficient of variationcoefficient de variationvariatiecoëfficiënt
141131000172106Days sensor worn (observable entity)Days sensor wornnombre de jours de port du capteurdagen sensor gedragen
141141000172104Frequency of hyperglycaemic episodes (observable entity)Frequency of hyperglycaemic episodescrise hyperglycémique d'origine diabétiquenombre d'événements hypoglycémiqueshyperglycemische ontregeling bij diabetes mellitusaantal ernstige hyperglycemische voorvallen
141241000172105GMI (Glucose Management Index)Glucose management indexparamètre calculé sur la base du taux de glucose moyenparameter berekend op basis van het gemiddelde glucosegehalte
365845005Hemoglobin A1C - diabetic control finding (finding)Haemoglobin A1C - diabetic control findingHemoglobin A1C - diabetic control findingobservation concernant le niveau d'HbA1c (hémoglobine A1c) comme indicateur du contrôle diabétiqueconstatation concernant le taux d'hémoglobine A1c dans l'équilibre diabétiquebevinding betreffende hemoglobine A1c voor glykemische controlebevinding betreffende hemoglobine A1c bij diabetescontrole
141151000172102Mean number of point-of-care capillary blood glucose measurements per day (observable entity)Mean number of point-of-care capillary blood glucose measurements per daynombre moyen de scans par jourgemiddeld aantal scans per dag
141161000172100Mean substance concentration of glucose in capillary blood using minimally-invasive continuous glucose monitoring device (observable entity)Mean substance concentration of glucose in capillary blood using minimally-invasive continuous glucose monitoring deviceglucose moyengemiddelde glucose
141171000172109Number of clinically significant hypoglycaemic episodes recorded by continuous glucose monitoring device (observable entity)Number of clinically significant hypoglycaemic episodes recorded by continuous glucose monitoring devicenombre d'épisodes hypoglycémiques cliniquement significatifs enregistrés par un dispositif de 'monitoring' continu du glucosenombre d'épisodes hypoglycémiques cliniquement pertinents enregistrés par un dispositif de surveillance continue de la glycémiehypoglykemie bij diabetes mellitusaantal ernstige hypoglycemische voorvallen
141181000172107Percentage of data captured (observable entity)Percentage of data capturedpourcentage de données capturéespercentage gegevenspercentage opgenom
141191000172105Percentage of time above level 1 hyperglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device (observable entity)Percentage of time above level 1 hyperglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring devicetemps pendant lequel la valeur glycémique est dans l'intervalle 'haut' de la catégorie diabétiquetijd waarin de glycemische waarde binnen het 'hoog' interval van de categorie ligt
141201000172108Percentage of time above level 2 hyperglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device (observable entity)Percentage of time above level 2 hyperglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring devicetemps pendant lequel la valeur glycémique est au-dessus du limite 'très haut' de la catégorie diabétiquetijd waarin de glycemische waarde boven het 'zeer hoog' bereik van de categorie ligt
141211000172106Percentage of time below level 1 hypoglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device (observable entity)Percentage of time below level 1 hypoglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring devicetemps pendant lequel la valeur glycémique est dans l'intervalle 'bas' de la catégorie diabétiquetijd waarin de glycemische waarde binnen het interval 'laag' van de categorie ligt
141221000172101Percentage of time below level 2 hypoglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device (observable entity)Percentage of time below level 2 hypoglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring devicetemps pendant lequel la valeur glycémique est dans l'intervalle 'très bas' de la catégorie diabétiquetijd waarin de glycemische waarde binnen het interval 'zeer laag' van de categorie ligt
141231000172103Percentage of time in target glucose range to total glucose monitoring time using minimally-invasive continuous glucose monitoring device (observable entity)Percentage of time in target glucose range to total glucose monitoring time using minimally-invasive continuous glucose monitoring devicetemps pendant lequel la valeur glycémique est dans l'intervalle 'normal' de la catégorie diabétiquetijd waarin de glycemische waarde binnen het 'normaal' interval van de categorie ligt

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code